Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
biotech
clinical trials
dihydroergotamine
life sciences
medical device
national blog main
new york blog main
new york top stories
2
×
nirogacestat
san francisco blog main
san francisco top stories
satsuma pharmaceuticals
springworks therapeutics
10x genomics
acute migrane
bain capital
bausch health
biotech ipos
breast cancer
deals
desmoid tumor
desmoid tumors
dihydroergotamine mesylate
generic drug
generic drugs
glaxosmithkline
impel neuropharma
investing
migraine
multiple myeloma
national organization for rare disorders
new york
orbimed
pfizer
ra capital
raleigh-durham blog main
raleigh-durham top stories
rare disease drugs
rare diseases
renaissance capital
What
biotech
companies
2
×
ipo
satsuma
springworks
2
×
activity
boost
days
dog
drug
firm
followed
genomics
hasn’t
haul
ipos
leading
led
life
line
markets
migraine
pfizer
place
prep
public
science
securing
slowed
spinout
stopped
street
summer
wall
way
wednesday
week
week’s
welcomed
Language
unset
Current search:
photo
×
companies
×
" new york top stories "
×
springworks
×
@xconomy.com
5 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
5 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs